Tolvaptan in hospitalized cancer patients with hyponatremia: A double‐blind, randomized, placebo‐controlled clinical trial on efficacy and safety

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 744-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1453-1463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience

By Kumar Das Siddharth   Pareek Anil   Mathur D. S.   Wanchu Ajay   Srivastava Ragini   Agarwal G. G.   Chauhan R. S.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2227-2234

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience

By Pareek A.   Chandanwale A. S.   Oak J.   Jain U. K.   Kapoor S.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 977-988

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1048-1057

John Wiley & Sons Inc

Access to resources Recommend Favorite